Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays Andrew G. Bosanquet Review Pages: 197 - 207
Studies on the pharmacokinetics of chlorambucl and prednimustine in patients using a new high-performance liquid chromatographic assay Matthias M. OppitzEugen MuschBrigitte Mühenbruch Original Articles Pages: 208 - 212
Preclinical pharmacology of the anthrapyrazole analog oxantrazole (NSC-349174, Piroxantrone) Sandra K. FrankDane A. MathiesenMatthew M. Ames Original Articles Pages: 213 - 218
Toxicity and antitumor activity of cis-bis-carboxylato(trans-R,R-1,2-diaminocyclohexane) platinum(II) complexes entrapped in liposomes A. R. KnokharS. Al-BakerR. Perez-Soler Original Articles Pages: 219 - 224
Tumor inhibition by titanocene complexes: influence on xenografted human adenocarcinomas of the gastrointestinal tract P. Köpf-Maier Original Articles Pages: 225 - 230
Exacerbation of toxic effects by endotoxin contamination of recombinant human tumor necrosis factor Yukio OzakiToshio OyamaShoji Kume Original Articles Pages: 231 - 237
Adriamycin-Lipiodol suspension for i. a. chemotherapy of hepatocellular carcinoma Yoshihiro KatagiriKazuhide MabuchiToshio Kawai Original Articles Pages: 238 - 242
Pharmacokinetics of (glycolato-0,0′)-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin Yasutsuna SasakiTomohide TamuraKazuhiko Nakagawa Original Articles Pages: 243 - 246
Pharmacokinetics of a new anticancer drug, navelbine, in patients P. BoréR. RahmaniJ. P. Cano Original Articles Pages: 247 - 251
Cisplatin with high-dose infusions of hydroxyurea to inhibit DNA repair Brian M. J. CantwellDaniel VealeAdrian L. Harris Original Articles Pages: 252 - 254
Effects of sodium thiosulfate in combination therapy of cis-dichlorodiammineplatinum and vindesine Akira HirosawaHisanobu NiitaniEitaka Tsuboi Original Articles Pages: 255 - 258
Oral dipyridamole and methotrexate in human solid tumors: a toxicity trial Celestia S. HiganoRobert B. Livingston Original Articles Pages: 259 - 262
Treatment of refractory and relapsed non-Hodgkin's lymphoma with ifosfamide, methotrexate and etoposide Graeme SangsterW. Nigel PattonMichael J. Leyland Original Articles Pages: 263 - 265
Phase I trial of a new nitrosourea, CGP 6809, given every 2 weeks Patrick J. CreavenJ. Wayne CowensDenise Traynor Short Communication Pages: 266 - 267
International Conference on Triazenes: Chemical, Biological and Clinical Aspects Announcement Pages: 268 - 268
